Efficacy of iron and/or zinc supplementation on cognitive performance of lead-exposed Mexican schoolchildren: A randomized, placebo-controlled trial

Javier Alatorre Rico, Katarzyna Kordas, Patricia López, Jorge L. Rosado, Gonzalo García Vargas, Dolores Ronquillo, Rebecca J. Stoltzfus

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

OBJECTIVE. Lead exposure in children has been associated with both global and specific cognitive deficits. Although chelation therapy is advised for children with blood lead concentrations of >44 μg/dL, treatment options for children with lower blood lead values are limited. Because lead absorption is related to children's nutritional status, micronutrient supplements may be 1 strategy for combating low-level, chronic lead exposure. This study was designed to test the efficacy of iron and zinc supplementation for lowering blood lead concentrations and improving cognitive performance in schoolchildren who live in a lead-contaminated city. METHODS. This randomized, double-blind, placebo-controlled field trial was conducted in public elementary schools in Torreón, an industrialized city in northern Mexico. A metal foundry, located close to the city center and within 3.5 km of 9 schools, was the main source of lead exposure. A total of 602 children who were aged 6 to 8 years and regularly attending first grade in the study schools were enrolled. Children were given 30 mg of iron, 30 mg of zinc, both, or a placebo daily for 6 months. A total of 527 completed the treatment, and 515 were available for long-term follow-up, after another 6 months without supplementation. Eleven cognitive tests of memory, attention, visual-spatial abilities, and learning were administered at baseline and each follow-up. RESULTS. There were no consistent or lasting differences in cognitive performance among treatment groups. CONCLUSIONS. Daily supplementation with iron and/or zinc may be of limited usefulness for improving cognition in lead-exposed schoolchildren. However, these treatments may be effective in settings with higher prevalence of nutritional deficiencies or in younger children.

Original languageEnglish (US)
Pages (from-to)e518-e527
JournalPediatrics
Volume117
Issue number3
DOIs
StatePublished - Mar 1 2006

Fingerprint

Zinc
Iron
Randomized Controlled Trials
Placebos
Chelation Therapy
Micronutrients
Therapeutics
Mexico
Lead
Nutritional Status
Malnutrition
Cognition
Metals

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Rico, J. A., Kordas, K., López, P., Rosado, J. L., Vargas, G. G., Ronquillo, D., & Stoltzfus, R. J. (2006). Efficacy of iron and/or zinc supplementation on cognitive performance of lead-exposed Mexican schoolchildren: A randomized, placebo-controlled trial. Pediatrics, 117(3), e518-e527. https://doi.org/10.1542/peds.2005-1172
Rico, Javier Alatorre ; Kordas, Katarzyna ; López, Patricia ; Rosado, Jorge L. ; Vargas, Gonzalo García ; Ronquillo, Dolores ; Stoltzfus, Rebecca J. / Efficacy of iron and/or zinc supplementation on cognitive performance of lead-exposed Mexican schoolchildren : A randomized, placebo-controlled trial. In: Pediatrics. 2006 ; Vol. 117, No. 3. pp. e518-e527.
@article{527d28e00a254e9eb1ddb43462e4e718,
title = "Efficacy of iron and/or zinc supplementation on cognitive performance of lead-exposed Mexican schoolchildren: A randomized, placebo-controlled trial",
abstract = "OBJECTIVE. Lead exposure in children has been associated with both global and specific cognitive deficits. Although chelation therapy is advised for children with blood lead concentrations of >44 μg/dL, treatment options for children with lower blood lead values are limited. Because lead absorption is related to children's nutritional status, micronutrient supplements may be 1 strategy for combating low-level, chronic lead exposure. This study was designed to test the efficacy of iron and zinc supplementation for lowering blood lead concentrations and improving cognitive performance in schoolchildren who live in a lead-contaminated city. METHODS. This randomized, double-blind, placebo-controlled field trial was conducted in public elementary schools in Torre{\'o}n, an industrialized city in northern Mexico. A metal foundry, located close to the city center and within 3.5 km of 9 schools, was the main source of lead exposure. A total of 602 children who were aged 6 to 8 years and regularly attending first grade in the study schools were enrolled. Children were given 30 mg of iron, 30 mg of zinc, both, or a placebo daily for 6 months. A total of 527 completed the treatment, and 515 were available for long-term follow-up, after another 6 months without supplementation. Eleven cognitive tests of memory, attention, visual-spatial abilities, and learning were administered at baseline and each follow-up. RESULTS. There were no consistent or lasting differences in cognitive performance among treatment groups. CONCLUSIONS. Daily supplementation with iron and/or zinc may be of limited usefulness for improving cognition in lead-exposed schoolchildren. However, these treatments may be effective in settings with higher prevalence of nutritional deficiencies or in younger children.",
author = "Rico, {Javier Alatorre} and Katarzyna Kordas and Patricia L{\'o}pez and Rosado, {Jorge L.} and Vargas, {Gonzalo Garc{\'i}a} and Dolores Ronquillo and Stoltzfus, {Rebecca J.}",
year = "2006",
month = "3",
day = "1",
doi = "10.1542/peds.2005-1172",
language = "English (US)",
volume = "117",
pages = "e518--e527",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

Efficacy of iron and/or zinc supplementation on cognitive performance of lead-exposed Mexican schoolchildren : A randomized, placebo-controlled trial. / Rico, Javier Alatorre; Kordas, Katarzyna; López, Patricia; Rosado, Jorge L.; Vargas, Gonzalo García; Ronquillo, Dolores; Stoltzfus, Rebecca J.

In: Pediatrics, Vol. 117, No. 3, 01.03.2006, p. e518-e527.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Efficacy of iron and/or zinc supplementation on cognitive performance of lead-exposed Mexican schoolchildren

T2 - A randomized, placebo-controlled trial

AU - Rico, Javier Alatorre

AU - Kordas, Katarzyna

AU - López, Patricia

AU - Rosado, Jorge L.

AU - Vargas, Gonzalo García

AU - Ronquillo, Dolores

AU - Stoltzfus, Rebecca J.

PY - 2006/3/1

Y1 - 2006/3/1

N2 - OBJECTIVE. Lead exposure in children has been associated with both global and specific cognitive deficits. Although chelation therapy is advised for children with blood lead concentrations of >44 μg/dL, treatment options for children with lower blood lead values are limited. Because lead absorption is related to children's nutritional status, micronutrient supplements may be 1 strategy for combating low-level, chronic lead exposure. This study was designed to test the efficacy of iron and zinc supplementation for lowering blood lead concentrations and improving cognitive performance in schoolchildren who live in a lead-contaminated city. METHODS. This randomized, double-blind, placebo-controlled field trial was conducted in public elementary schools in Torreón, an industrialized city in northern Mexico. A metal foundry, located close to the city center and within 3.5 km of 9 schools, was the main source of lead exposure. A total of 602 children who were aged 6 to 8 years and regularly attending first grade in the study schools were enrolled. Children were given 30 mg of iron, 30 mg of zinc, both, or a placebo daily for 6 months. A total of 527 completed the treatment, and 515 were available for long-term follow-up, after another 6 months without supplementation. Eleven cognitive tests of memory, attention, visual-spatial abilities, and learning were administered at baseline and each follow-up. RESULTS. There were no consistent or lasting differences in cognitive performance among treatment groups. CONCLUSIONS. Daily supplementation with iron and/or zinc may be of limited usefulness for improving cognition in lead-exposed schoolchildren. However, these treatments may be effective in settings with higher prevalence of nutritional deficiencies or in younger children.

AB - OBJECTIVE. Lead exposure in children has been associated with both global and specific cognitive deficits. Although chelation therapy is advised for children with blood lead concentrations of >44 μg/dL, treatment options for children with lower blood lead values are limited. Because lead absorption is related to children's nutritional status, micronutrient supplements may be 1 strategy for combating low-level, chronic lead exposure. This study was designed to test the efficacy of iron and zinc supplementation for lowering blood lead concentrations and improving cognitive performance in schoolchildren who live in a lead-contaminated city. METHODS. This randomized, double-blind, placebo-controlled field trial was conducted in public elementary schools in Torreón, an industrialized city in northern Mexico. A metal foundry, located close to the city center and within 3.5 km of 9 schools, was the main source of lead exposure. A total of 602 children who were aged 6 to 8 years and regularly attending first grade in the study schools were enrolled. Children were given 30 mg of iron, 30 mg of zinc, both, or a placebo daily for 6 months. A total of 527 completed the treatment, and 515 were available for long-term follow-up, after another 6 months without supplementation. Eleven cognitive tests of memory, attention, visual-spatial abilities, and learning were administered at baseline and each follow-up. RESULTS. There were no consistent or lasting differences in cognitive performance among treatment groups. CONCLUSIONS. Daily supplementation with iron and/or zinc may be of limited usefulness for improving cognition in lead-exposed schoolchildren. However, these treatments may be effective in settings with higher prevalence of nutritional deficiencies or in younger children.

UR - http://www.scopus.com/inward/record.url?scp=33645019697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645019697&partnerID=8YFLogxK

U2 - 10.1542/peds.2005-1172

DO - 10.1542/peds.2005-1172

M3 - Article

C2 - 16510631

AN - SCOPUS:33645019697

VL - 117

SP - e518-e527

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

ER -